Literature DB >> 8272412

Development of new lipophilic derivatives of tetragastrin: physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats.

T Tenma1, E Yodoya, S Tashima, T Fujita, M Murakami, A Yamamoto, S Muranishi.   

Abstract

In order to improve the intestinal absorption of tetragastrin (TG), we synthesized lipophilic derivatives of TG by acylation of its N-terminal amino group with acetic acid, caproic acid, and lauric acid. The purified TG derivatives, acetyl-tetragastrin (Ac-TG), caproyl-tetragastrin (Cap-TG), and lauroyl-tetragastrin (Lau-TG), were confirmed to be more lipophilic than the parent TG by high-performance liquid chromatography (HPLC). The pharmacological activities and the intestinal absorption of TG and its derivatives were examined by measuring gastric acid secretion. Stimulation of gastric acid secretion by these derivatives after intravenous administration was stronger than with native TG. When the acetyl- and caproyl-derivatives were administered into the large intestinal loops, a marked increase in gastric acid secretion was observed in comparison with TG, while no significant effect occurred following administration of the TG derivatives into the small intestines. These results indicated that chemical modification of TG with fatty acids improves the absorption of TG from the large intestines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272412     DOI: 10.1023/a:1018983511247

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Improvement of intestinal absorption of thyrotropin-releasing hormone by chemical modification with lauric acid.

Authors:  K Yamada; M Murakami; A Yamamoto; K Takada; S Muranishi
Journal:  J Pharm Pharmacol       Date:  1992-09       Impact factor: 3.765

2.  Continuous recording of acid gastric secretion in the rat.

Authors:  M N GHOSH; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1958-03

Review 3.  Absorption enhancers.

Authors:  S Muranishi
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1990       Impact factor: 4.889

4.  The absorption of tetragastrin from different sites in rats and dogs.

Authors:  H M Jennewein; F Waldeck; W Konz
Journal:  Arzneimittelforschung       Date:  1974-08

5.  Enzymatic degradation of C-terminal tetrapeptide amide of gastrin by mammalian tissue extracts.

Authors:  L Laster; J H Walsh
Journal:  Fed Proc       Date:  1968 Nov-Dec

6.  Structure-function relationships in the active C-terminal tetrapeptide sequence of gastrin.

Authors:  J S Morley; H J Tracy; R A Gregory
Journal:  Nature       Date:  1965-09-25       Impact factor: 49.962

7.  Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.

Authors:  H Bundgaard; J Møss
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

8.  Improvement of large intestinal absorption of insulin by chemical modification with palmitic acid in rats.

Authors:  M Hashizume; T Douen; M Murakami; A Yamamoto; K Takada; S Muranishi
Journal:  J Pharm Pharmacol       Date:  1992-07       Impact factor: 3.765

9.  Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids.

Authors:  Y Lapidot; S Rappoport; Y Wolman
Journal:  J Lipid Res       Date:  1967-03       Impact factor: 5.922

10.  Lipophilic peptides: synthesis of lauroyl thyrotropin-releasing hormone and its biological activity.

Authors:  S Muranishi; A Sakai; K Yamada; M Murakami; K Takada; Y Kiso
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

View more
  8 in total

1.  Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.

Authors:  T Uchiyama; A Kotani; H Tatsumi; T Kishida; A Okamoto; N Okada; M Murakami; T Fujita; Y Fujiwara; Y Kiso; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.

Authors:  A Yamamoto; T Taniguchi; K Rikyuu; T Tsuji; T Fujita; M Murakami; S Muranishi
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

3.  Position of lipidation influences anticancer activity of Smac analogs.

Authors:  Ewa D Micewicz; Christine Nguyen; Alina Micewicz; Alan J Waring; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2019-04-26       Impact factor: 2.823

4.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

Review 5.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

6.  Stability of acyl derivatives of insulin in the small intestine: relative importance of insulin association characteristics in aqueous solution.

Authors:  H Asada; T Douen; Y Mizokoshi; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

7.  Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors.

Authors:  T Fujita; I Kawahara; Y Quan; K Hattori; K Takenaka; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

8.  A two-step strategy to enhance activity of low potency peptides.

Authors:  Jamie R Doyle; Benjamin N Harwood; Subrahmanian Tarakkad Krishnaji; Vijay M Krishnamurthy; Wei-En Lin; Jean-Philippe Fortin; Krishna Kumar; Alan S Kopin
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.